- Today's Hot Chat Topics
- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Glaxosmithkline Share News (GSK)
Share News for Glaxosmithkline (GSK)
| Share Price: 1,749.50 | Bid: 1,747.00 | Ask: 1,747.50 | Change: 0.00 (0.00%) |  | ||||||
| ||||||||||
US STOCKS-Wall St flat after retail sales, Nasdaq edges higher
* Core U.S. retail sales rise 0.5 percent in April* Yum Brands falls as monthly Chinese sales drop* Crude oil falls, pressuring energy companies* Inde[13 May '13]
US STOCKS-Wall St dips but rise in retail sales limits decline
* Core U.S. retail sales rise 0.5 percent in April* Yum Brands falls as monthly Chinese sales drop* Crude oil falls, pressuring energy companies* Inde[13 May '13]
US STOCKS-Wall St dips but rise in retail sales limits decline
* Elan to buy part of U.S. drug firm Theravance's royalty for $1 billion* Core U.S. retail sales rise 0.5 percent in April* Indexes off: Dow 0.21 pct,[13 May '13]
Elan-Theravance deal a big boost for Baupost, Fidelity
By Tim McLaughlinBOSTON, May 13 (Reuters) - Fidelity Investments and hedge fund Baupost Group LLC got a lift on Monday from their investment in Thera[13 May '13]
US STOCKS-Wall St set to dip at open after record high
* Elan, Theravance reach royalties deal* Retail sales edge up in April* Futures off: Dow 17 pts, S&P 2.1 pts, Nasdaq 2.5 ptsBy Chuck MikolajczakNEW YO[13 May '13]
Late payment costs European companies 350 billion euros
* European businesses forced to write off 3 pct of receivables* Late payment hitting southern Europe harder than the north* Business confidence down a[13 May '13]
UPDATE 3-Elan's $1 bln drug royalty deal aids bid defence
* Elan to acquire newly approved Breo as part of deal* Company says further deals in pipeline* A fifth of royalties to be paid to shareholders* CEO sa[13 May '13]
US STOCKS-Futures dip after record high; retail sales on tap
* Elan, Theravance reach royalties deal* Retail sales for April on tap* Futures off: Dow 37 pts, S&P 4.8 pts, Nasdaq 10.25 ptsBy Chuck MikolajczakNEW[13 May '13]
